MGX
Metagenomi Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$1.475
Максимум
$1.475
Минимум
$1.475
Объем
0.25M
Фундаментальные показатели компании
Статистические данные торговли
Связанные новости
Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12
Chardan Capital analyst Geulah Livshits maintains Metagenomi with a Buy and lowers the price target from $13 to $12.
Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16
Wells Fargo analyst Yanan Zhu maintains Metagenomi with a Overweight and lowers the price target from $20 to $16.
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate
Metagenomi to Present at Upcoming Scientific Meetings
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing
Связанные акции
ALSAU
Alpha Star Acquisition Corporation Units
CNTB
Connect Biopharma Holdings Limited American Depositary Shares
ALRN
Aileron Therapeutics Inc.
ATI
ATI Inc.
DCOMG
Dime Community Bancshares Inc. 9.000% Fixed-to-Floating Rate Subordinated Notes due 2034
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.